María J. Buzón
- Virology top 0.2%
- HIV Research and Treatment 59
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 28
- HIV/AIDS Research and Interventions 21
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
- Immunology top 2%
- Immune Cell Function and Interaction 32
- T-cell and B-cell Immunology 10
- Immunotherapy and Immune Responses 4
- Emergency Medicine top 2%
- Epidemiology top 5%
María J. Buzón
64 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Virology 2.5k
- Infectious Diseases 1.6k
- Immunology 1.1k
- Emergency Medicine 388
- Epidemiology 479
Countries citing papers authored by María J. Buzón
This map shows the geographic impact of María J. Buzón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María J. Buzón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María J. Buzón more than expected).
Fields of papers citing papers by María J. Buzón
This network shows the impact of papers produced by María J. Buzón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María J. Buzón. The network helps show where María J. Buzón may publish in the future.
Co-authorship network
The 25 scholars most cited alongside María J. Buzón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 16 | |
| 7 | 2019 | 34 | |
| 8 | 2019 | 81 | |
| 9 | 2018 | 22 | |
| 10 | 2015 | 8 | |
| 11 | 2014 | 40 | |
| 12 | 2014 | 18 | |
| 13 | Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialbreakdown → | 2014 | 472 |
| 14 | 2014 | 313 | |
| 15 | 2013 | 50 | |
| 16 | 2013 | 106 | |
| 17 | 2013 | 55 | |
| 18 | 2012 | 20 | |
| 19 | 2008 | 29 | |
| 20 | 2008 | 5 |
About María J. Buzón
María J. Buzón is a scholar working on Virology, Infectious Diseases and Immunology, having authored 66 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (59 papers), Immune Cell Function and Interaction (32 papers), HIV/AIDS drug development and treatment (28 papers), HIV/AIDS Research and Interventions (21 papers), T-cell and B-cell Immunology (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Immunotherapy and Immune Responses (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (2.5k citations), Infectious Diseases (1.6k citations) and Immunology (1.1k citations). María J. Buzón has collaborated with scholars based in Spain, United States and Australia. Frequent co-authors include Mathias Lichterfeld, Javier Martínez‐Picado, Xu G. Yu, Florencia Pereyra, Bruce D. Walker, Zhengyu Ouyang, Sarah Palmer, Eric Rosenberg, Ryan Zurakowski and Rikke Olesen. Their work appears in journals such as Nature Medicine, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.